The α2-selective adrenoceptor antagonist org 3770 (mirtazapine, Remeron®) enhances noradrenergic and serotonergic transmission
- 1 July 1995
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 10 (S2) , S107-S118
- https://doi.org/10.1002/hup.470100805
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Which Depressed Patients Should Receive Antidepressants?CNS Drugs, 1994
- Effects of imipramine and mirtazapine on operant performance in ratsDrug Development Research, 1994
- Electrophysiologic Evidence for Desensitization of α2-Adrenoceptors on Serotonin Terminals Following Long-Term Treatment with Drugs Increasing Norepinephrine Synaptic ConcentrationNeuropsychopharmacology, 1994
- Cross-familiarisation conditioned taste aversion procedure as a method to reveal stimulus resemblance between drugs: studies on the 5-HT1A agonist 8-OHDPATPsychopharmacology, 1993
- The effect of adrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studied by in vivo voltammetryEuropean Journal of Pharmacology, 1992
- Behavioural evidence for functional interactions between 5‐HT‐receptor subtypes in rats and miceBritish Journal of Pharmacology, 1990
- Selective activation of 5HT1A receptors induces lower lip retraction in the ratPharmacology Biochemistry and Behavior, 1989
- Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomersNeuropharmacology, 1988
- Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonistsNeuropharmacology, 1980